Pharma Cos. Will Open Abandoned Drugs To Outside Research

Law360, New York (May 3, 2012, 3:10 PM EDT) -- Three major pharmaceutical companies will allow outside scientists to examine potential drug compounds that the companies began developing but abandoned, in the hopes that the scientists will come up with new marketable therapies, under a new government-funded program announced Thursday.

The companies, Pfizer Inc., AstraZeneca PLC and Eli Lilly & Co., will give researchers access to up to 24 chemical compounds and their related scientific data, which the companies spent years developing and had to shelve either for business reasons or because the compounds turned out...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.